Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmacoepidemiology and Drug Safety is Scopus-indexed (Q2, CiteScore 3.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 1053-8569Verify ISSN ↗1099-1557Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: About US$4,650 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Epidemiology | 74 / 173 | 57th | Q2 |
| Pharmacology (medical) | 143 / 278 | 48th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1992–present, best quartile Q2, CiteScore 3.8.
Pharmacoepidemiology and Drug Safety is Q2 in Epidemiology (rank 74 of 173) and Q3 in Pharmacology (medical) (rank 143 of 278), by CiteScore 2025.
Pharmacoepidemiology and Drug Safety is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.8, which places it in quartile Q2 at the 57th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.041, quartile Q1, with an H-index of 117.
The publisher lists an article processing charge of about US$4,650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Pharmacoepidemiology and Drug Safety is published by John Wiley and Sons Ltd. Its print ISSN is 1053-8569 and its online ISSN is 1099-1557.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Pharmacoepidemiology and Drug Safety has an h-index of 136 and a 2-year mean of 2.21 citations per paper (OpenAlex). Its Scopus CiteScore is 3.8, quartile Q2. On 2-year citations it ranks #60 of 171 Scopus journals in Epidemiology.
Pharmacoepidemiology and Drug Safety published 245 papers in 2025; its busiest recent year was 2021 with 289. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from United States (30.2%), Japan (9.5%) and Brazil (8.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (1 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.